Research Topics
| Mauro MoscucciSummaryAffiliation: University of Michigan Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary interventionRonald S McKechnie
Blue Cross Blue Shield of Michigan Cardiovascular Consortium BMC2, USA
Circulation 110:271-7. 2004..Therefore, we evaluated the relationship between anemia and outcomes of PCI...- Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical databaseMauro Moscucci
Division of Cardiology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0311, USA
J Am Coll Cardiol 46:625-32. 2005..The aim of our study was to evaluate the volume-outcome relationship in a large, quality-controlled, contemporary percutaneous coronary interventions (PCI) database... - Frequency and prognosis of emergency coronary artery bypass grafting after percutaneous coronary intervention for acute myocardial infarctionMauro Moscucci
University of Michigan, Division of Cardiology, Blue Cross Blue Shield of Michigan Cardiovascular Consortium Coordinating Center, Ann Arbor, Michigan, USA
Am J Cardiol 92:967-9. 2003..In this study, emergency CABG occurred in 2% of cases, and was associated with high in-hospital mortality (20%) and with a high incidence of stroke (8%), renal failure requiring dialysis (8.3%), and bleeding (63.3%)... - Percutaneous coronary intervention complications and guide catheter size: bigger is not betterP Michael Grossman
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Hospitals and Health System and Veterans Administration Ann Arbor Health System, Ann Arbor, MI 48109 5869, USA
JACC Cardiovasc Interv 2:636-44. 2009..We evaluated the association between guiding catheter size and complications of percutaneous coronary intervention (PCI)... - Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary interventionSandeep M Jani
Division of Cardiology, University of Michigan Medical Centers, Ann Arbor, USA
Clin Cardiol 30:II49-56. 2007..A randomized controlled trial is needed to determine the value of transfusion and the ideal transfusion criteria... - Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2])Debabrata Mukherjee
University of Michigan Health System, Ann Arbor, Michigan, USA
Am J Cardiol 92:972-4. 2003..The underlying cause of this significant association is unclear, but it warrants further investigation in an attempt to improve outcome in this high-risk cohort... - Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular ConsortiumHitinder S Gurm
University of Michigan, Ann Arbor, MI 48103 0311, USA
J Interv Cardiol 20:197-203. 2007..To evaluate the safety and efficacy of bivalirudin based therapy among patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease in a large multicenter registry... - The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary interventionHitinder S Gurm
University of Michigan, Ann Arbor, Michigan 48103 0311, USA
J Am Coll Cardiol 51:529-35. 2008.... - Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventionsMauro Moscucci
Division of Cardiology, Blue Cross Blue Shield of Michigan Cardiovascular Consortium Coordinating Center, University of Michigan, Ann Arbor, Michigan, USA
Circulation 113:814-22. 2006..The objective of this study was to evaluate the association of a continuous quality improvement program with practice and outcome variations of percutaneous coronary intervention (PCI)... - Temporal trends in the use of drug-eluting stents for approved and off-label indications: a longitudinal analysis of a large multicenter percutaneous coronary intervention registrySarah K Gualano
Department of Internal Medicine, Division of Cardiovascular Medicine, The University of Michigan, Ann Arbor, Michigan, USA
Clin Cardiol 33:111-6. 2010.... - Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databasesMauro Moscucci
University of Michigan Health System, Ann Arbor, Michigan, USA
J Am Coll Cardiol 45:1759-65. 2005..The purpose of this research was to determine the potential effect of public reporting on case selection for percutaneous coronary intervention (PCI)... - Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary interventionBrahmajee K Nallamothu
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
Am J Cardiol 92:964-6. 2003..0 to 2.0, p = 0.029). When extracardiac vascular disease was separated into cerebrovascular disease and peripheral vascular disease, cerebrovascular disease was less common but was associated with a trend towards worse survival... - Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventionsHitinder S Gurm
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
J Am Coll Cardiol 58:907-14. 2011..The aim of this study was to evaluate the association between calculated creatinine clearance (CCC)-based contrast dose and renal complications in patients undergoing percutaneous coronary interventions (PCI)... - Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionAnneliese Flynn
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, USA
Arch Intern Med 170:1842-9. 2010..Therefore, our objective was to determine whether a decline in DTB time in patients with STEMI was associated with an improvement in clinical outcomes... - The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Michael C Reed
University of Michigan School of Medicine, Ann Arbor, Michigan, USA
J Invasive Cardiol 22:467-72. 2010..There was no difference in the adjusted risk of CI-AKI among patients treated with iodixanol compared with those treated with LOCM... - Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitusThomas F Boyden
University Michigan Medical School, Ann Arbor VA Medical Center, Ann Arbor, Michigan, USA
Am J Cardiol 99:1399-402. 2007..001). DES use is associated with a marked decrease in in-stent restenosis and target lesion revascularization in patients with diabetes. In conclusion, the analysis supports the current widespread use of DESs in these high-risk patients... - Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experienceEva Kline-Rogers
University of Michigan, Division of Cardiology, Blue Cross Blue Shield of Michigan Cardiovascular Consortium Coordinating Center, Ann Arbor, Michigan, USA
J Interv Cardiol 15:387-92. 2002..In conclusion, the number of queries and diagnostic reports generated in the database suggests that the development of a quality-controlled PCI registry requires the institution of a careful diagnostic and data quality assessment system... - Improving outcomes of percutaneous coronary intervention through the application of guidelines and benchmarking: reduction of major bleeding and blood transfusion as a modelStanley J Chetcuti
University of Michigan Cardiovascular Center, Ann Arbor, Michigan 48109 5869, USA
Clin Cardiol 30:II44-8. 2007..We describe a model for the application of a continuous quality improvement program including benchmarking and available guidelines for blood transfusion, aimed toward reducing transfusion rates among patients undergoing PCI... - Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registryChristos Kasapis
Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, MI 48109 5869, USA
Circ Cardiovasc Interv 3:593-601. 2010..We sought to correlate total heparin dose and peak procedural activated clotting time (ACT) with postprocedural outcomes in patients undergoing PVI... - The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Elizabeth A Jackson
Department of Internal Medicine, Division of Cardiovascular Medicine, The University of Michigan, Ann Arbor, MI, USA
Am Heart J 161:106-112.e1. 2011..It is unclear if these differences persist among patients undergoing contemporary primary percutaneous coronary intervention (PCI) with focus on early reperfusion... - Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complicationsApurva A Motivala
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
Am J Cardiol 100:1359-63. 2007.... - Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)Rabeea Aboufakher
Division of Cardiology, Oakwood Hospital, Dearborn, Michigan, USA
Am Heart J 150:455-8. 2005..The identification of risk factors for HF could foster the development of interventions aimed toward its prevention in high-risk patients... - Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysisShea E Hogan
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109 5853, USA
Am Heart J 156:414-21. 2008..The purpose of this meta-analysis is to compare the effectiveness of normal saline (NS) versus sodium bicarbonate hydration (NaHCO(3)) for prevention of contrast-induced AKI... - The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trialsMichael Reed
University of Michigan School of Medicine, VA Ann Arbor Healthcare System, University of Michigan, Ann Arbor, MI 48109 5853, USA
JACC Cardiovasc Interv 2:645-54. 2009..We sought to compare the nephrotoxicity of the iso-osmolar contrast medium, iodixanol, to low-osmolar contrast media (LOCM)... - Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registryClaire S Duvernoy
University of Michigan Medical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 48105 2399, USA
Am Heart J 159:677-683.e1. 2010..Prior studies have shown a relationship between female gender and adverse outcomes after percutaneous coronary interventions (PCIs). Whether this relationship still exists with contemporary PCI remains to be determined... - Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromesDebabrata Mukherjee
University of Michigan, Ann Arbor, Mich, USA
Circulation 109:745-9. 2004..However, the impact of the combination of these agents on clinical outcomes has not been studied before... - Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast doseRosario V Freeman
Division of Cardiology, University of Washington, Seattle, Washington, USA
Am J Cardiol 90:1068-73. 2002..A risk prediction tool for NRD with guidelines for prevention is presented... - Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trialsUmesh U Tamhane
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
BMC Cardiovasc Disord 10:10. 2010..The objective of our study was to systematically evaluate currently available data comparing thrombectomy followed by PCI with conventional PCI alone in patients with acute STEMI... - The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventionsMauro Moscucci
University of Michigan, Division of Cardiology, Blue Cross Blue Shield of Michigan Cardiovascular Consortium Coordinating Center, Ann Arbor, Michigan, USA
J Interv Cardiol 15:381-6. 2002.... - Shelf-price agreements: the next frontier in competitive bidding for coronary intervention suppliesRobert K Keast
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109-0311, USA
J Cardiovasc Manag 16:27-30. 2005..The results suggest that this strategy can further reduce supply costs while maintaining collaborative relationships with vendors... - Reducing costs and improving outcomes of percutaneous coronary interventionsMauro Moscucci
Division of Cardiology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, 48109 0119, USA
Am J Manag Care 9:365-72. 2003..To describe cost reduction and quality improvement efforts in our percutaneous coronary intervention (PCI) program and how risk adjustment was used to assess the effects of these changes... - Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary interventionKrishna G Aragam
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, 48109, USA
Am Heart J 161:544-551.e2. 2011..We determined the incidence and determinants of cardiac rehabilitation referral rates for patients undergoing percutaneous coronary intervention (PCI)... - Screening for myocardial infarction and ischemic stroke: a population-based studyDevin L Brown
Stroke Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA
Neuroepidemiology 29:96-100. 2007..Screening for abnormal cardiac biomarkers to identify potential MI cases may be more accurate and efficient than using ICD-9 codes... - Patient comprehension of an interactive, computer-based information program for cardiac catheterization: a comparison with standard informationAlan R Tait
Department of Anesthesiology, University of Michigan Health System, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA
Arch Intern Med 169:1907-14. 2009..The present study examines the effect of an interactive computer-based information program on patients' understanding of cardiac catheterization... - Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular ConsortiumMichael P Thomas
Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109 5853, USA
Clin Cardiol 34:549-54. 2011..Accordingly, we assessed the impact of age on outcome of a large cohort of patients undergoing PCI in a regional collaborative registry... - Partnering with payers to improve surgical quality: the Michigan planNancy J O Birkmeyer
Michigan Surgical Collaborative for Outcomes Research and Evaluation, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
Surgery 138:815-20. 2005 - Prognostic implication of troponin I elevation after percutaneous coronary interventionBrahmajee K Nallamothu
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
Am J Cardiol 91:1272-4. 2003 - Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary interventionHitinder S Gurm
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109 5853, USA
JACC Cardiovasc Interv 5:98-104. 2012..The aim of this study was to examine the use of and outcomes associated with use of N-acetylcysteine (NAC) in real-world practice... - Competitive bidding for interventional cardiology supplies: lessons learned during round 2Kim A Eagle
Department of Internal Medicine, University of Michigan Health System, Ann Arbor, USA
Am J Manag Care 8:384-8. 2002..To assess the magnitude of savings and develop concepts for "best strategies" in reducing costs in the purchasing of high-technology, high-cost materials used in coronary interventions and electrophysiologic treatments... - Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)Debabrata Mukherjee
Division of Cardiology, University of Michigan, Ann Arbor, USA
Circulation 106:1909-12. 2002..Peripheral vascular disease is a manifestation of systemic atherosclerosis and is associated with an increased risk of cardiovascular morbidity and mortality... - Percutaneous closure of an iatrogenic atrial septal defectJames P Sur
Division of Cardiovascular Medicine, Department of Internal Medicine, The University of Michigan Health Systems, Ann Arbor, Michigan 48109 5869, USA
Catheter Cardiovasc Interv 73:267-71. 2009..With closure of the ASD using an 8-mm Amplatzer septal occluder (ASO; AGA Medical Corp., Golden Valley, MN) the patient stabilized and was successfully extubated... - Double-wire technique for access into a protruding aorto-ostial stent for treatment of in-stent restenosisStanley J Chetcuti
Division of Cardiology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan 48103, USA
Catheter Cardiovasc Interv 62:214-7. 2004..Treatment was only possible after a guidewire advanced through a lower strut was used to lever the guide, and a second guidewire was advanced through the true lumen... - Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysisBrahmajee K Nallamothu
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109 0311, USA
Am J Med 117:938-47. 2004..Although previous meta-analyses have concluded that acetylcysteine is beneficial, the recent availability of additional trials calls for reassessment of current evidence... - Frequency and costs of ischemic and bleeding complications after percutaneous coronary interventions: rationale for new antithrombotic agentsMauro Moscucci
Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
J Invasive Cardiol 14:55B-64B. 2002 - Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])Frederick A Spencer
Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
Am J Cardiol 90:1056-61. 2002.... - Coronary revascularization before noncardiac surgeryMauro Moscucci
N Engl J Med 351:2861-3. 2004 - From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)Keith A A Fox
Department of Cardiology, The Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh EH3 9YW, Scotland, UK
Eur Heart J 24:1414-24. 2003..The gap between evidence and practice is well recognized but the factors influencing this disjunction, and the extent to which such factors are modifiable, remain uncertain... - Coronary revascularization before noncardiac vascular surgery: one more step forward in understanding its roleMauro Moscucci
J Am Coll Cardiol 49:1770-1. 2007 - Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventionsSanjaya Khanal
Henry Ford Heart and Vascular Institute, Henry Ford Hospital, Detroit, Mich 48202, USA
Am J Med 118:843-9. 2005..Along with lowering serum cholesterol, statins have pleiotropic effects in the vasculature. The effect of statin use on CIN is unknown... - ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Spencer B King
Circulation 116:98-124. 2007 - ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Spencer B King
J Am Coll Cardiol 50:82-108. 2007 - Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionElizabeth H Bradley
Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
Crit Pathw Cardiol 6:91-7. 2007..In conclusion, although evidence of "what works" is based on observational studies rather than randomized trials, there is evidence on effective interventions to reduce door-to-balloon time... - Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer
Department of Medicine, McMaster University, Faculty of Health Sciences, 1200 Main St W, Hamilton, Canada, L8N 3Z5
Circulation 116:2793-801. 2007..Because these data are not generalizable to all patients with acute myocardial infarction, we sought to better understand the scope of this problem in a "real-world" setting... - Door-to-balloon time in primary percutaneous coronary intervention: is the 90-minute gold standard an unreachable chimera?Mauro Moscucci
Circulation 113:1048-50. 2006 - Reducing the door-to-balloon time for myocardial infarction with ST-segment elevationMauro Moscucci
N Engl J Med 355:2364-5. 2006 - Development of a multicenter peripheral arterial interventional database: the PVD-QI2Debabrata Mukherjee
Gill Heart Institute, Division of Cardiovascular Medicine, Lexington, KY 40436-0200, USA
Am Heart J 149:1003-8. 2005....